Overexpression of C16orf74 is involved in aggressive pancreatic cancers

Clinical outcome of pancreatic ductal adenocarcinoma (PDAC) has not been improved in the last three decades due to the lack of effective molecular-targeted drugs. To identify a novel therapeutic target for PDAC, we have performed genome-wide anamysis and found that Homo sapiens chromosome 16 open re...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Oncotarget
Hauptverfasser: Nakamura, Toru, Katagiri, Toyomasa, Sato, Shoki, Kushibiki, Toshihiro, Hontani, Koji, Tsuchikawa, Takahiro, Hirano, Satoshi, Nakamura, Yusuke
Format: Artigo
Sprache:Inglês
Veröffentlicht: Impact Journals LLC 2016
Schlagworte:
Research Paper
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5584151/
https://ncbi.nlm.nih.gov/pubmed/28881575
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.10912
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge